Yarrow Safety: Thujone, Asteraceae Allergy and Pregnancy

This is the page most articles about yarrow leave out, and it is the one that actually changes what a reader should do. Yarrow is widely described as "gentle," "safe," and "a mild traditional tea," and for a great many healthy adults drinking an occasional cup that description is fair. But yarrow carries five specific issues that are documented rather than speculative, and each of them identifies a group of people for whom yarrow is a genuinely poor choice: it contains thujone, the neuroactive constituent that puts wormwood and sage in a caution class of their own; it is an Asteraceae (Compositae) plant with well-characterized contact-allergy chemistry and broad cross-reactivity; it has reported photosensitivity; it is contraindicated in pregnancy; and it carries a theoretical bleeding-drug interaction plus a reason for caution in epilepsy.

There is also a sixth, entirely practical problem that undermines all of the above: you often cannot be sure what plant is in the packet. The garden ornamental Achillea cultivars are not the medicinal wild type, and "yarrow" on a label may be either. That section is at the end and is more important than it sounds.

Nothing here is a reason for a healthy non-pregnant adult without daisy-family allergy to be frightened of yarrow tea. It is a reason to know which group you are in before you start.


Table of Contents

  1. Thujone: The Wormwood and Sage Caution Class
  2. What Thujone Means in Practice
  3. Asteraceae Allergy and Cross-Reactivity
  4. Documented Contact Dermatitis and Patch Testing
  5. Photosensitivity
  6. Pregnancy and Breastfeeding: A Contraindication
  7. The Anticoagulant and Antiplatelet Question
  8. Seizure Threshold and Epilepsy
  9. Other Drug Interactions
  10. The Essential Oil Is a Different Risk Category
  11. Which Plant Is Actually in the Packet?
  12. Who Should Avoid Yarrow
  13. Practical Rules if You Do Use It
  14. Key Research Papers
  15. Connections

Thujone: The Wormwood and Sage Caution Class

Yarrow's essential oil contains thujone — a bicyclic monoterpene ketone that exists as α- and β-thujone. This is the same compound that made absinthe notorious, and it is the reason wormwood (Artemisia absinthium), sage (Salvia officinalis), tansy and thuja are all handled with restrictions that mild herbs are not. Yarrow belongs in that group. It is generally at the lower end of it — wormwood oil can be far richer in thujone — but the caution class is the same, and yarrow's thujone content is variable rather than negligible.

The pharmacology is understood, which is unusual for a herbal safety concern. Höld and colleagues, publishing in the Proceedings of the National Academy of Sciences (2000) in a paper on α-thujone as the active component of absinthe, showed that α-thujone is a modulator of the GABA-A receptor — specifically a non-competitive blocker of the GABA-gated chloride channel — and characterized its rapid metabolic detoxification. GABA is the brain's principal inhibitory neurotransmitter. Blocking inhibition is, mechanistically, how convulsant drugs work: at sufficient dose thujone produces excitation and seizures in animals. The same paper's detoxification findings explain why moderate exposure is tolerated — thujone is metabolized quickly — which is exactly why dose and duration are the variables that matter. (Evidence tier: established pharmacology, animal and in-vitro.)

Two myths should be cleared away, because they cut in both directions. Thujone did not cause the hallucinations attributed to absinthe in the nineteenth century; the reconstructed thujone content of historical absinthe was far too low, and modern analyses of surviving and reconstructed absinthe support the unglamorous conclusion that absinthe's harms were mostly those of a very strong alcoholic drink. Lachenmeier's work on wormwood as a plant with both neurotoxic and neuroprotective properties, in the Journal of Ethnopharmacology (2010), covers this ground. But the opposite myth — that thujone is therefore harmless and the concern was invented — is also wrong: thujone is a real GABA-A antagonist with a real convulsant dose, which is why regulators still cap it in food and medicines.

Back to Table of Contents

What Thujone Means in Practice

Thujone is regulated. European food law limits thujone in alcoholic beverages, and the European Medicines Agency's herbal committee has issued a public statement on herbal medicinal products containing thujone, setting out an exposure limit and a duration restriction for thujone-containing preparations. Lachenmeier and Uebelacker's risk assessment of thujone in foods and medicines containing sage and wormwood, in Regulatory Toxicology and Pharmacology (2010), examined whether those limits were set correctly — the existence of that debate is itself the point: this is a constituent taken seriously enough to have a regulatory exposure limit, which is not true of most herbal constituents.

For a reader, four practical consequences follow:

  1. Short courses, not continuous use. This is the single most useful rule. Occasional or short-term yarrow tea is a different exposure from a daily tincture taken for a year. Traditional practice happens to agree — bitters and fever teas were used in bouts, around meals or during illness — and regulatory duration limits on thujone-containing herbal products formalize the same idea.
  2. Modest amounts. A cup of tea from a teaspoon of dried herb delivers a small fraction of what a concentrated extract does. Escalating the dose because a small one "didn't do much" is the wrong instinct with a thujone-containing herb.
  3. Water extracts are lower risk than alcohol extracts or oil. Thujone is a volatile, lipophilic terpene, so it partitions into essential oil and, less so, into alcohol tinctures; a covered infusion carries some but not all of it. The essential oil is the highest-exposure form by a wide margin and should never be swallowed.
  4. Variability means you cannot calculate your exposure. Thujone content varies by chemotype, geography, harvest time and preparation. Nobody drinking yarrow tea knows their thujone dose. That uncertainty is an argument for the first three rules rather than for alarm.

Back to Table of Contents

Asteraceae Allergy and Cross-Reactivity

Yarrow is a member of the Asteraceae family, also called Compositae — the daisy family, one of the largest plant families on earth. This is not a botanical footnote; it is the most likely way yarrow will cause a problem for an ordinary person.

Asteraceae sensitivity is common, and it cross-reacts. Someone who reacts to one member of the family frequently reacts to others, because the responsible compounds are shared. If you have trouble with any of the following, treat yarrow as a likely problem:

The chemistry behind the cross-reactivity is specific: sesquiterpene lactones. These are the same bitter compounds that give yarrow its digestive rationale and part of its anti-inflammatory activity. They are also potent contact sensitizers, and because the family shares them, sensitization to one plant transfers to others. This is why a "sesquiterpene lactone mix" and a Compositae mix are standard allergens in dermatological patch-test series — the problem is common enough to have earned a permanent place on the panel.

Reactions span the usual range. Contact dermatitis is the classic and best documented. Airborne contact dermatitis affects gardeners and florists handling large amounts of daisy-family plants. Oral or systemic reactions to ingested Asteraceae herbs are less common but described, and anaphylaxis to chamomile in ragweed-sensitive individuals is a documented, if rare, event — which is why "it's only a herbal tea" is not a safe assumption for someone with strong daisy-family allergy. (Evidence tier: established clinical allergology, case series and case reports.)

Back to Table of Contents

Documented Contact Dermatitis and Patch Testing

Yarrow specifically — not just "the daisy family" — has been chemically pinned down as a cause of allergic contact dermatitis. Hausen, Breuer, Weglewski and Rücker reported in Contact Dermatitis (1991) on "α-peroxyachifolid and other new sensitizing sesquiterpene lactones from yarrow (Achillea millefolium L., Compositae)," isolating the specific molecules responsible. That is an unusually well-characterized herbal adverse effect: the plant, the compound class and the individual sensitizers are all identified.

Paulsen's work on Compositae dermatitis, including a survey in Contact Dermatitis (1992) and later work on contact sensitization from Compositae-containing herbal remedies and cosmetics (2002), places yarrow in the broader clinical picture — a family that turns up repeatedly in dermatitis from herbal creams, ointments and "natural" cosmetics. Yarrow extract is a fairly common cosmetic ingredient, which means people are exposed to it without seeking it out.

Practical guidance follows directly:

Back to Table of Contents

Photosensitivity

Standard herbal safety references list photosensitivity among yarrow's adverse effects, and there are case reports of photodermatitis attributed to Achillea species — that is, skin reactions occurring where treated skin was exposed to sunlight. The literature here is small, the responsible constituents are not as cleanly identified as the contact-allergy sesquiterpene lactones, and it is not always easy to separate a photosensitive reaction from ordinary contact dermatitis on sun-exposed skin.

Given that, the sensible reading is: the signal is real enough to appear in reference works, thin enough that nobody can quantify the risk. The practical response is cheap — if you apply yarrow to skin, keep the treated area out of strong sun for a day or so, and stop if you get a reaction that maps onto sun exposure. (Evidence tier: case reports and reference-work listings; no systematic study.)

Back to Table of Contents

Pregnancy and Breastfeeding: A Contraindication

Yarrow should not be used internally during pregnancy. This is not a hedge; it is the consistent position of herbal reference works, regulatory monographs and safety reviews, and two independent reasons support it.

The emmenagogue tradition. Yarrow is classed throughout the historical literature as an emmenagogue — a plant believed to provoke menstrual flow — and such plants appear in the historical record of substances used to interrupt pregnancy. There is no reliable evidence that yarrow has any such effect at realistic doses, and there is equally no evidence that it is safe. The traditional signal is a reason for precaution, not proof of harm. This is discussed further on the menstrual and pelvic page.

Thujone. Thujone-containing herbs are avoided in pregnancy as a class. A GABA-A-active neuroactive terpene crossing to a developing nervous system, at an unknown dose, with no safety data, is not a risk anyone should accept for a herb whose benefits are traditional. The same logic keeps wormwood and sage-oil products off the list in pregnancy.

Breastfeeding has not been studied, so the same precaution applies. Children are another gap: traditional-use herbal registrations for yarrow are typically restricted to adults, or to adults and adolescents, because there is no paediatric data — and thujone plus an unknown dose in a small body is exactly the situation to avoid.

If someone has drunk yarrow tea before realising they were pregnant, the message is reassurance rather than alarm: there is no evidence of harm from ordinary tea-level exposure, the advice above is precautionary, so stop and mention it at the next appointment.

Back to Table of Contents

The Anticoagulant and Antiplatelet Question

Yarrow appears on standard lists of herbs with a theoretical interaction with anticoagulant and antiplatelet drugs — warfarin, direct oral anticoagulants, aspirin, clopidogrel and the rest. Two features make this worth taking seriously despite being theoretical.

First, the direction is genuinely unclear. Yarrow's folk reputation is styptic — stopping bleeding — and rests on a single old animal report on the alkaloid achilleine, described on the wound page. Simultaneously, its coumarin and flavonoid content is the basis for listing it as a possible antiplatelet or anticoagulant. Both claims are weak, they contradict each other, and no human study has resolved them. An unpredictable effect on coagulation in someone whose coagulation is being deliberately controlled by a drug is a worse situation than a known effect in either direction.

Second, the consequences of getting anticoagulation wrong are serious in both directions — bleeding on one side, clot or stroke on the other. Warfarin in particular has a narrow therapeutic window and a long list of documented herbal interactions; Ge, Zhang and Zuo's review of clinically evidenced herb–warfarin interactions in Evidence-Based Complementary and Alternative Medicine (2014) and Izzo and Ernst's updated systematic review of interactions between herbal medicines and prescribed drugs in Drugs (2009) are the standard entry points to that literature.

Practical position: if you take an anticoagulant or antiplatelet drug, or have a bleeding disorder, do not add yarrow without asking your prescriber or pharmacist, and if you are on warfarin do not start or stop it without INR monitoring. It is also conventional to stop yarrow and similar herbs a week or two before surgery or dental extraction, and to tell the anaesthetist what you have been taking. (Evidence tier: theoretical interaction; no human interaction studies specific to yarrow.)

Back to Table of Contents

Seizure Threshold and Epilepsy

This follows directly from the thujone pharmacology and is routinely omitted from herbal writing. Because α-thujone blocks the GABA-A chloride channel — reducing inhibitory signalling — thujone-containing preparations are considered capable of lowering the seizure threshold, and high-dose exposure to thujone-rich essential oils is a recognised cause of convulsions. Clinical toxicology literature includes reports of seizures following ingestion of sage or wormwood essential oil, which is precisely why those oils are not for internal use.

Yarrow tea is not wormwood oil, and there is no body of case reports of yarrow tea causing seizures. But the direction of effect is not in doubt, and the relevant advice is straightforward:

(Evidence tier: established mechanism plus case reports for concentrated thujone-rich oils; no yarrow-specific human data.)

Back to Table of Contents

Other Drug Interactions

Beyond the bleeding question, the interactions attributed to yarrow are pharmacologically plausible and clinically unstudied. They are worth knowing so you can raise them with a pharmacist, who can check them against your actual medication list:

Note the honest framing on all of these: they are extrapolations from constituent pharmacology, not measured interactions. That means they are neither dismissible nor established, and the correct response is a two-minute conversation with a pharmacist rather than either worry or bravado.

Back to Table of Contents

The Essential Oil Is a Different Risk Category

Everything above becomes several-fold more serious with the steam-distilled essential oil, sometimes sold as "blue yarrow" for its chamazulene content. An essential oil concentrates the volatile constituents — including thujone — by a very large factor relative to the herb. The rules are not fussy, they are the actual safety margin:

If a source recommends taking yarrow essential oil internally, that is a reliable signal to stop trusting the source.

Back to Table of Contents

Which Plant Is Actually in the Packet?

This section is the practical one that almost nobody covers, and it quietly undermines every dose and safety statement above.

Achillea millefolium in the broad sense is not one plant. Written A. millefolium s.l., it is an aggregate of closely related populations differing in chromosome number and in chemistry. Whether a given plant produces the proazulene precursors that yield blue chamazulene on distillation tracks with its ploidy level, so two batches of "yarrow oil" can differ fundamentally — one deep blue and anti-inflammatory, one not. Essential-oil composition also shifts with geography, altitude, soil, harvest timing and drying, which is why antimicrobial studies from different countries report different potencies for the same nominal species. Thujone content varies along with everything else.

Garden ornamental Achillea is not the medicinal plant. The flat yellow, brick-red, coral and cream border perennials sold in garden centres — the named cultivars — are largely hybrids involving other Achillea species such as A. filipendulina. They are bred for flower colour and stem strength, not for the traditional constituent profile, and they should not be treated as interchangeable with wild A. millefolium. Harvesting the border for tea is not the traditional practice, whatever the plant label says.

Three consequences worth acting on:

  1. Buy botanically identified material — a supplier that names Achillea millefolium L., states the plant part (herb or flower), and ideally the origin. "Yarrow extract" with no botanical name tells you nothing.
  2. Do not assume the flower bed is the herbal. If you want wild yarrow, identify it properly: feathery many-times-divided leaves, flat-topped clusters of small mostly-white flower heads, and the characteristic aromatic smell when a leaf is crushed. Several toxic members of the carrot family also have finely cut leaves and flat flower clusters and have caused fatal misidentifications — if you are not confident, do not forage.
  3. Expect batch-to-batch variation even from a good supplier. That variability is itself an argument for modest amounts and short courses.

Back to Table of Contents

Who Should Avoid Yarrow

Consolidated, so it can be read in one pass. Avoid yarrow, or use it only after speaking to a clinician or pharmacist, if you:

Back to Table of Contents

Practical Rules if You Do Use It

For a healthy non-pregnant adult with no daisy-family allergy, none of the above makes yarrow forbidding. These are the rules that keep it in the low-risk zone where its traditional reputation belongs:

  1. Short courses. Days to a couple of weeks, around meals or during a cold, rather than daily and indefinitely.
  2. Modest amounts. Roughly a teaspoon of dried herb per cup, or the labelled drops of tincture. Do not escalate.
  3. Tea rather than oil. Prefer the water infusion; keep the cup covered while steeping. Never swallow the essential oil.
  4. Patch-test any topical preparation and read cosmetic labels if you have daisy-family allergy — yarrow extract turns up in creams.
  5. One new thing at a time. If you start yarrow and something changes, you want to know what caused it.
  6. Tell your prescriber and pharmacist that you are taking it, and list it before any surgery. Herbs belong on the medication list.
  7. Stop if anything unexpected happens — rash, itching, nausea, dizziness, headache, or a reaction on sun-exposed skin — and do not resume to test it.
  8. Do not use it to postpone a diagnosis. This is the biggest risk on the page and it has nothing to do with chemistry: a herb used to manage a symptom that needs investigating causes harm through delay.

Back to Table of Contents


Key Research Papers

All links are PubMed topic searches, so results stay current. Titles, journals and years appear in the text.

  1. Höld KM, Sirisoma NS, Ikeda T, Narahashi T, Casida JE. "α-Thujone (the active component of absinthe): γ-aminobutyric acid type A receptor modulation and metabolic detoxification." Proceedings of the National Academy of Sciences, 2000 — the GABA-A mechanism and rapid detoxification. PubMed: alpha-thujone GABA receptor absinthe
  2. Lachenmeier DW, Uebelacker M. "Risk assessment of thujone in foods and medicines containing sage and wormwood — evidence for a need of regulatory changes?" Regulatory Toxicology and Pharmacology, 2010 — how thujone exposure limits are derived and argued over. PubMed: thujone risk assessment sage wormwood
  3. Lachenmeier DW. "Wormwood (Artemisia absinthium L.) — a curious plant with both neurotoxic and neuroprotective properties?" Journal of Ethnopharmacology, 2010 — dismantles the absinthe-hallucination myth without dismissing thujone. PubMed: Artemisia absinthium thujone neurotoxic
  4. Hausen BM, Breuer J, Weglewski J, Rücker G. "α-Peroxyachifolid and other new sensitizing sesquiterpene lactones from yarrow (Achillea millefolium L., Compositae)." Contact Dermatitis, 1991 — identifies yarrow's specific contact sensitizers. PubMed: Achillea millefolium sensitizing sesquiterpene lactones
  5. Paulsen E. "Compositae dermatitis: a survey." Contact Dermatitis, 1992; and "Contact sensitization from Compositae-containing herbal remedies and cosmetics." Contact Dermatitis, 2002 — the clinical picture of daisy-family dermatitis, including from herbal products. PubMed: Compositae dermatitis herbal remedies cosmetics
  6. Spinella M. "Herbal medicines and epilepsy: the potential for benefit and adverse effects." Epilepsy & Behavior, 2001 — which herbs raise seizure concern, and why thujone plants recur. PubMed: herbal medicine epilepsy seizure threshold
  7. Izzo AA, Ernst E. "Interactions between herbal medicines and prescribed drugs: an updated systematic review." Drugs, 2009 — the reference framework for herb–drug interaction claims. PubMed: herbal medicines prescribed drugs interactions systematic review
  8. Ge B, Zhang Z, Zuo Z. "Updates on the clinical evidenced herb-warfarin interactions." Evidence-Based Complementary and Alternative Medicine, 2014 — why anticoagulation plus an unstudied herb is a poor combination. PubMed: herb warfarin interaction clinical evidence
  9. Cavalcanti AM, Baggio CH, Freitas CS, et al. "Safety and antiulcer efficacy studies of Achillea millefolium L. after chronic treatment in Wistar rats." Journal of Ethnopharmacology, 2006 — one of the few chronic-dosing animal safety assessments of yarrow. PubMed: Achillea millefolium chronic toxicity safety rats
  10. Ali SI, Gopalakrishnan B, Venkatesalu V. "Pharmacognosy, Phytochemistry and Pharmacological Properties of Achillea millefolium L.: A Review." Phytotherapy Research, 2017 — constituent profile, including the variable essential oil. PubMed: Achillea millefolium essential oil thujone composition
  11. Applequist WL, Moerman DE. "Yarrow (Achillea millefolium L.): A Neglected Panacea?" Economic Botany, 2011 — includes the taxonomic complexity of the A. millefolium aggregate. PubMed: Achillea millefolium aggregate taxonomy chemotype
  12. Literature on essential-oil ingestion and seizures, including clinical toxicology reports involving sage and wormwood oils — the reason thujone-containing oils are never taken internally. PubMed: essential oil ingestion seizures toxicity
  13. Work on Asteraceae pollen cross-reactivity, including mugwort and ragweed sensitization patterns — the basis for the cross-reactivity warnings above. PubMed: mugwort ragweed cross-reactivity Asteraceae allergy
  14. Case reports and reference listings of photosensitivity attributed to Achillea — a thin but real literature. PubMed: Achillea photodermatitis photosensitivity

Live PubMed Searches

  1. Achillea millefolium adverse effects
  2. Thujone toxicity seizure
  3. Sesquiterpene lactone mix patch test
  4. Herbal medicine pregnancy safety review
  5. Achillea millefolium allergy anaphylaxis
  6. Herbal supplement species authentication

External Resources

Back to Table of Contents

Connections

Back to Table of Contents


Safety and disclaimer. This page is educational and is not medical advice, and it does not replace advice from your own doctor or pharmacist about your own medicines. Yarrow contains thujone and belongs to the same caution class as wormwood and sage: use modest amounts in short courses, and never swallow the essential oil. Do not use yarrow in pregnancy or while breastfeeding. Avoid it if you have epilepsy or a seizure history, or if you react to ragweed, mugwort, chamomile, feverfew, chrysanthemum, calendula or arnica — patch-test any topical preparation. Check with your prescriber before combining yarrow with anticoagulant, antiplatelet, sedative or blood-pressure medication, and stop it a week or two before surgery. Seek medical care for any symptom that is new, severe, worsening or unexplained rather than treating it with a herb.